BioVie Inc.
NASDAQTotal Valuation
BioVie Inc. carries a market capitalization of 2.52M, placing it among publicly traded companies globally. Its enterprise value stands at -8.70M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.52M |
| Enterprise Value | -8.70M |
Share Statistics
BioVie Inc. currently has 7.54M shares outstanding.
| Shares Outstanding | 7.54M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Financial Position
BioVie Inc. maintains a current ratio of 3.59, meaning it holds 3.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 2.68, indicating elevated leverage, while an interest coverage ratio of -1,255.43 demonstrates limited ability to service its debt obligations.
| Current Ratio | 3.59 |
| Quick Ratio | 2.93 |
| Debt / Equity | 2.68 |
| Debt / EBITDA | -0.01 |
| Interest Coverage | -1,255.43 |
Financial Efficiency
| Return on Equity (ROE) | -150.76 |
| Return on Assets (ROA) | -123.27 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
BioVie Inc.'s stock has gained approximately 18.24% over the past 52 weeks. The 50-day moving average sits at 0.32, while the 200-day moving average is 0.32.
| Beta (5Y) | N/A |
| 52-Week Price Change | 18.24% |
| 50-Day Moving Average | 0.32 |
| 200-Day Moving Average | 0.32 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -22.47M, while operating income came in at -22.65M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -22.65M |
| Pretax Income | -22.07M |
| Net Income | -22.07M |
| EBITDA | -22.47M |
| EBIT | -22.65M |
| Earnings Per Share (EPS) | N/A |
Balance Sheet
BioVie Inc. holds 8.98M in cash and equivalents against 275,430.00 in total debt, resulting in a net debt position of -8.98M. Total book value stands at 10.27M, with working capital of 9.85M providing operational flexibility.
| Cash & Cash Equivalents | 8.98M |
| Total Debt | 275,430.00 |
| Net Debt | -8.98M |
| Equity (Book Value) | 10.27M |
| Book Value Per Share | 1.36 |
| Working Capital | 9.85M |
Cash Flow
BioVie Inc. produced -19.02M in operating cash flow over the past twelve months.
| Operating Cash Flow | -19.02M |
| Capital Expenditures | N/A |
| Free Cash Flow | -19.02M |
| FCF Per Share | N/A |
Scores
BioVie Inc. posts an Altman Z-Score of -42.21, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -42.21 |